All In Biotech

Drug Trial Radar · NCT06729021

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

Predictive Efficacy of Modified Caprini Score and D-Dimer for the Evaluation and Management of Lower Extremity Venous Thrombosis Among Cardiothoracic Surgery Patients in Baghdad

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

112

Planned (sponsor's estimate)

Start

Jan 20, 2025

Primary completion

Jul 20, 2027

Study completion Jul 30, 2027

Sponsor

Lead sponsor
Al-Nahrain UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 11, 2024

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.

Conditions

  • DVT - Deep Vein Thrombosis

Interventions

  • GCSDevice

    Graduated compression stockings may be used after procedure by the decision of the doctor

  • LMWHDrug

    Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. any episode of VTE (Venous Thromboembolism)Time frame: In-Hospital Phase (average of 7 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30
  2. Caprini risk assessment model scoresTime frame: Day 1 preoperative (one day prior to surgery)
  3. Concentration of D-dimer in Blood SamplesTime frame: Day 1 postoperative (the first day after surgery)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • College of Medicine - Al-Nahrain University

    Baghdad, Iraq · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.